WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Short Interest Down 61.0% in March

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) was the target of a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 834 shares, a drop of 61.0% from the February 26th total of 2,136 shares. Based on an average daily volume of 3,129 shares, the short-interest ratio is currently 0.3 days.

WuXi AppTec Stock Performance

WuXi AppTec stock opened at $14.39 on Thursday. The stock has a 50-day moving average of $14.68 and a two-hundred day moving average of $14.08. WuXi AppTec has a one year low of $5.73 and a one year high of $16.35.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group raised WuXi AppTec to a “buy” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy”.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.